drugset / Trial / NCT00468533
The Monitor of Serum Prolactin Level in a 3 Months Aripiprazole Trial
RandomizedParallel-groupOpen-labelTreatment
Summary
A short term post-market monitoring of serum prolactin level change among patients with schizophrenia shifting from other antispychotics to different dosages of aripiprazole.
Timeline
- Start
- 2006-05
- Primary completion
- —
- Completion
- 2007-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aripiprazole | Other / unclassified | 10 mg | — |
| Subject | Aripiprazole | Other / unclassified | 15 mg | — |
| Subject | Aripiprazole | Other / unclassified | 20 mg | — |
| Subject | Aripiprazole | Other / unclassified | 30 mg | — |